The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s notice ...

Members of the House of Representatives and the Senate have re-introduced legislation that would create a complete home ...

The FDA today issued a notice warning of a potential high-risk issue with certain Baxter Spectrum infusion pump systems.

Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect dosing ...

Under federal law, device makers must submit adverse event reports they receive from patients to the FDA’s Manufacturer And User Facility Device Experience (MAUDE) database within 30 days, researchers ...

An increasing prevalence of chronic diseases is expected to drive the global infusion pump market to rise by $4.99b through ...

Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject ...

The "North America and Europe Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report by Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), Disease Indication (Chemotherapy), ...